Table 1

Antibodies against F. tularensis in patients determined by cELISA, iELISA, and MAa

PatientBlood collection (days after onset of tularemia)Test
cELISA (% inhibition)iELISA (OD)MA (titer)
P11125.80.60<10
3679.71.91320
P21254.11.8420
3774.52.65320
P33784.92.99>1,280
8380.43.07>1,280
P419.90.27<10
1343.40.7940
P5947.91.01<10
2577.32.1580
P68078.22.54320
P72182.82.57640
P8ND42.71.0280
P98775.82.66320
P101343.20.89<10
P115941.11.18160
P12ND36.10.79<10
P13879.22.49320
P147854.82.44>1,280
P15ND59.71.64>1,280
P164271.02.15640
8953.41.68320
P171342.02.84<10
241−1.51.3140
P181683.02.3640
2394.22.86160
3090.32.83160
5986.13.3480
18568.72.4240
P191666.60.9540
2365.31.19160
3066.21.18160
5979.01.62160
18560.21.0140
  • a A total of 34 serum samples of 19 patients were used. Sera of patients P1 to P5, P16, and P17 are paired samples obtained at the indicated days after the onset of tularemia symptoms. Patients P18 and P19 represent the five sets of samples obtained for several days after symptom onset. ND, not documented. Shaded numbers are values below the cutoff level in each test.